Catania. Myrmex lays off 62 employees and puts itself up for sale

Fedaisf editorial staff

January 2, 2017

The last calendar year, and also the previous one, they have seen many Myrmex employees battle for a long time to avoid being fired. However, the company of excellence in pharmaceutical research has given a cold shower to 62 employees last February.

All this despite the fact that 15 million euros had been financed. A struggle, however, continued even after, with the listing of Myrmex. After long discussions with unions and workers, ready to take the company, many were again dumbfounded: in fact, just a few days after the dismissal, the company it was put up for sale for €9 million.

From here, a new battle full of meetings with the president of the Sicilian Region, Rosario Crocetta, and the hope of succeeding in his goal and giving work to 62 people. A light that, however, has increasingly lost its intensity: nothing seems to have changed to date.

The latest protest dates back to last year December 7 in front of the former Palazzo ESA of Catania: Crocetta's words have not yet become reality.

( taken from “Sindacale: vertenze, licenziamenti, proteste, battaglie dure e infinite” – newsicilia.it – 02/01/2017)

Ed: Il colosso farmaceutico americano Pfizer cedette (come ramo d’azienda) il Laboratorio catanese (prima di Wyeth Lederle S.p.A): ad acquisirlo per 1€ fu la Myrmex di Gian Luca Calvi, nipote di Roberto Calvi. La cessione prevedeva anche 6.647.743,00 di euro a titolo di crediti finanziari del ramo d’azienda versati da Pfizer mediante bonifico bancario alla parte cessionaria, cioè a Myrmex. L’acquisizione del laboratorio comprendeva anche tutti i progetti di ricerca finanziati dal ministero dell’Istruzione, dell’Università e della Ricerca (MIUR). I ricercatori hanno sempre dichiarato di non avere mai lavorato un solo giorno.

Catania. Myrmex, yet another "no" from the company on the withdrawal of layoffs

Crac of Marvecspharma Service Srl, the Public Prosecutors ask for the trial for the Pfizer manager

Pharmaceuticals: Gup, 19 in trial for Marvecspharma crash, 4 plea bargains

The scam of employees of pharmaceutical companies bought and sold